Jasper Therapeutics, Inc. (JSPR)

NASDAQ: JSPR · IEX Real-Time Price · USD

23.21

-0.61 (-2.56%)

At close: Apr 18, 2024, 4:00 PM

23.11

-0.10 (-0.43%)

After-hours: Apr 18, 2024, 5:28 PM EDT

Jasper Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	350	88	18	297	125	126
Market Cap Growth	-	379.94%	-93.83%	137.48%	-0.60%	-
Enterprise Value	265	4	-17	215	107	99
PE Ratio	-1.37	-1.37	-0.49	-9.70	-3.95	-25.24
PB Ratio	4.46	1.12	0.51	4.27	-3.56	-26.59
P/FCF Ratio	-1.68	-1.68	-0.40	-8.23	-6.85	-63.93
P/OCF Ratio	-1.69	-1.69	-0.40	-8.82	-6.85	-63.93
EV/EBITDA Ratio	-0.06	-0.06	0.46	-7.15	-3.37	-22.16
EV/EBIT Ratio	-0.05	-0.05	0.44	-7.02	-3.36	-22.16
EV/FCF Ratio	-0.07	-0.07	0.36	-5.95	-5.83	-50.13
Debt / Equity Ratio	0.04	0.04	0.10	0.04	-0.05	-
Debt / EBITDA Ratio	-0.04	-0.04	-0.10	-0.10	-0.05	-
Debt / FCF Ratio	-0.05	-0.05	-0.08	-0.08	-0.09	-
Quick Ratio	7.06	7.06	5.57	10.60	5.18	13.63
Current Ratio	7.19	7.19	5.91	10.95	5.16	13.63
Interest Coverage	-	-	-	-	-	-8.36
Return on Equity (ROE)	-63.20%	-63.20%	-71.60%	-240.40%	629.30%	-
Return on Assets (ROA)	-55.10%	-55.10%	-58.30%	-47.90%	-38.60%	-
Return on Capital (ROIC)	-84.78%	-84.78%	-129.15%	-50.87%	61.73%	99.49%
Earnings Yield	-18.44%	-73.23%	-205.45%	-10.31%	-25.31%	-3.96%
FCF Yield	-14.97%	-59.45%	-253.15%	-12.15%	-14.60%	-1.56%
Buyback Yield / Dilution	-186.15%	-186.15%	-220.19%	-85.99%	-35.80%	-
Total Shareholder Return	-186.15%	-186.15%	-220.19%	-85.99%	-35.80%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).